Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biochemistry Research International|July 18, 2017
Synthesis and Evaluation of In Vitro Antibacterial and Antitumor Activities of Novel N,N-Disubstituted Schiff BasesHeng Luo, Yu-Fen Xia, Bao-Fei Sun, et al.
Vaccine|March 20, 2012
Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trialYan-Ping Li, Zheng-Lun Liang, Qiang Gao, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 17, 2019
The clinical features and reproductive prognosis of ovarian neoplasms with hyperandrogenemia: a retrospective analysis of 33 casesShan Shu, Shan Deng, Jie Qin Tian, et al.
Vaccine|April 15, 2023
Safety and immunogenicity of a pichia pastoris-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine in healthy Chinese women aged 9-45 years: A randomized, double-blind, placebo-controlled phase 1 clinical trialJuan Li, Li-Wei Shi, Bang-Wei Yu, et al.
Human Vaccines & Immunotherapeutics|May 30, 2023
Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese femalesLi-Wei Shi, Juan Li, Bang-Wei Yu, et al.
Vaccine|November 4, 2024
Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9-14-year-old and 18-26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trialJuan Li, Li-Wei Shi, Ke Li, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trialZhao-Jun Mo, Shou-Jie Huang, Ling-Xian Qiu, et al.
Pageof 2